Respiratory Infections News

Twenty-eight months after identifying its first case, the United States is nearing what President Joe Biden this week called “a tragic milestone”: 1 million COVID-19 deaths.

Moderna’s COVID-19 vaccine was found to be safe and effective among children aged 6 to 11 years, according to interim phase 2/3 findings from the KidCOVE trial published in The New England Journal of Medicine.

Researchers in the United Kingdom developed a novel tool they said can assess the symptoms of long COVID and help deliver clinical care.

The FDA has approved a new indication for Olumiant as a treatment for adults hospitalized with COVID-19 who require supplemental oxygen, noninvasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation.

The results of a systematic review and meta-analysis suggest there is an increased risk for tuberculosis among people with cytomegalovirus infection, researchers reported in The Lancet.

The Infectious Diseases Society of America issued guidance to help clinicians manage drug interactions between Paxlovid and the 100 most prescribed medications.

The FDA has restricted the use of Johnson & Johnson’s COVID-19 vaccine based on an updated analysis of the risk for a rare but potentially deadly blood-clotting syndrome.

Nearly 15 million people died as a direct or indirect result of COVID-19 during the first 24 months of the pandemic, according to a new estimate published Thursday by WHO.

A randomized controlled trial in India demonstrated that 12 months of oral itraconazole was superior to a 6-month regimen in reducing relapses of chronic pulmonary aspergillosis, researchers reported in The Lancet Infectious Diseases.

DENVER — The interleukin-1 inhibitor anakinra has little to no effect on moderate to severe multisystem inflammatory syndrome in children, according to researchers.